Our columnist suggests how to think about stocks and bonds during a presidency that is signaling a deep devotion to profits.

SINGAPORE: The updated JN.1 Novavax/Nuvaxovid COVID-19 vaccine will be offered under the national vaccination programme at ...

The U.S. Department of Health and Human Services has awarded Moderna (MRNA) $590M to “advance the late-stage development of its mRNA bird flu ...

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...

The U.S. Department of Health and Human Services or HHS said it will provide approximately $590 million to Moderna (MRNA) to ...

We recently compiled a list of the 10 Best High-Yield Dividend Stocks To Invest In. In this article, we are going to take a ...

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

Dylan Lewis: We're talking three stocks down bad. Motley Fool Money starts down. I'm Dylan Lewis, I'm joined over the ...

Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The ...

The Motley Fool reaches millions of people every month through our premium investing solutions, free guidance and market analysis on Fool.com, personal finance education, top-rated podcasts, and ...

President Donald Trump's boost to AI demand hopes is outweighing fresh tariff threats on China and the EU, as earnings season ...

Netflix earnings after the bell drive focus in tech stocks. Dow and S&P climb as optimism over trade policy fuels market ...